Viking Therapeutics Inc.
VKTX | NASDAQ
$30.11
+$1.12 (+3.86%)
At close: Sep 21, 2026, 4:00 PM ET
$39.01
+$8.90 (+29.56%)
Pre-market:
Sep 22, 2026, 8:37 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -534.8M | -472.34M | -359.64M | -237.39M | -171.55M | -128.24M | -109.96M | -99.15M | -96.75M | -93.72M | -85.9M | -80.85M | -74.09M | -72.3M | -68.87M | -61.66M | -59.13M | -57.08M | -54.99M | -53.58M | -49.63M | -43.82M |
Depreciation & Amortization | -843K | -6.59M | -5.27M | -5.25M | -5.28M | 383K | 346K | 310K | 296K | 294K | 292K | 290K | 359K | 286K | 291K | 295K | 228K | 301K | 296K | 291K | 286K | 281K |
Stock-Based Compensation | 37.39M | 39.81M | 40.82M | 37.9M | 39.54M | 33.08M | 29.71M | 28.13M | 23.62M | 21.16M | 16.75M | 14.83M | 12.29M | 9.89M | 8.67M | 7.95M | 7.61M | 6.88M | 6.1M | 5.71M | 5.59M | 5.74M |
Other Working Capital | 18.17M | 36.24M | 464K | -22.22M | -4M | -27.15M | 5.86M | 16.1M | 9M | 25.99M | 4.49M | 1.69M | 3.3M | -1.92M | 2.64M | 189K | -1.68M | -545K | -1.56M | 1.12M | 1.79M | 2.58M |
Other Non-Cash Items | -5.44M | -474K | -3.57M | -5.78M | -8.82M | -17.56M | -17.25M | -15.92M | -10.85M | -7.36M | -4.93M | -2.34M | -2.15M | 282K | 1.32M | 2.16M | 2.9M | 3.46M | 3.94M | 4.41M | 4.58M | 4.38M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.15M | -3.15M | -3.15M | -3.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 85.24M | 99.26M | 48.98M | -14.05M | -6.43M | -21.65M | 9.36M | 12.38M | 14.87M | 27.9M | 3.55M | 4.55M | 3.09M | -668K | 10.19M | 1.44M | 1.15M | -795K | -2.93M | 2.45M | 4.06M | 5.06M |
Operating Cash Flow | -418.44M | -340.33M | -278.69M | -224.58M | -152.54M | -133.99M | -87.79M | -74.25M | -71.95M | -54.87M | -73.38M | -66.66M | -60.5M | -62.51M | -48.4M | -49.82M | -47.25M | -47.24M | -47.59M | -40.72M | -35.12M | -28.35M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -204.44M | -257.86M | -418.04M | -514.5M | -643.04M | -749.38M | -1.11B | -1.07B | -1B | -1.02B | -478.3M | -425.38M | -356.42M | -148.14M | -121.43M | -112.4M | -126.12M | -150.02M | -168.02M | -165.41M | -249.92M | -272.88M |
Sales Maturities Of Investments | 478.01M | 298.51M | 593.43M | 620.87M | 615.28M | 719.05M | 560M | 549.72M | 440.7M | 376.43M | 299.22M | 217.82M | 188.29M | 203.48M | 176.18M | 187.3M | 187.74M | 196.23M | 205.98M | 206.23M | 267.49M | 296.67M |
Other Investing Acitivies | 125.69M | 291.68M | 165.99M | 165.99M | 165.99M | n/a | n/a | n/a | -12.53K | -12.53K | -10.34K | -10.34K | 29.09K | 29.09K | 26.89K | 26.89K | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 399.26M | 332.33M | 341.39M | 272.36M | 138.24M | -30.33M | -553.37M | -524.22M | -562.65M | -641.08M | -179.09M | -207.56M | -168.13M | 55.33M | 54.75M | 74.9M | 61.63M | 46.21M | 37.96M | 40.82M | 17.57M | 23.79M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -37K | -37K | -37K | -1.71M | -6.8M | -6.8M | -6.8M | -5.12M | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 85.58M | 85.58M | 73.95M | 47.66M | 3.52M | 6.45M | 15.37M | -302.05M | -259.88M | -268.22M | -271.24M | 9.14M | 11.11M | 16.6M | 10.21M | -415K | -649K | -733K | -707K | -243K | -178K | 238K |
Financial Cash Flow | 111.25M | 88.17M | 76.44M | 2.34M | 4.38M | 6.78M | 612.46M | 611.65M | 609.06M | 873.23M | 271.38M | 281.94M | 282.02M | 13.35M | 4.16M | -6.54M | -6.81M | -3.32M | 6.88M | 7.3M | 7.59M | 6.11M |
Net Cash Flow | 92.08M | 80.18M | 139.13M | 50.03M | -10.04M | -157.64M | -28.84M | 13.16M | -25.6M | 177.22M | 18.88M | 7.78M | 53.29M | 5.91M | 10.26M | 18.14M | 7.4M | -4.35M | -2.75M | 7.39M | -9.96M | 1.55M |
Free Cash Flow | -418.44M | -340.33M | -278.69M | -224.58M | -152.54M | -133.99M | -87.79M | -74.25M | -71.95M | -54.87M | -73.38M | -66.66M | -60.5M | -62.51M | -48.4M | -49.82M | -47.25M | -47.24M | -47.59M | -40.72M | -35.12M | -28.35M |
Adj. Free Cash Flow | -455.83M | -380.14M | -319.5M | -262.47M | -192.08M | -167.07M | -117.5M | -102.37M | -95.57M | -76.03M | -90.13M | -81.49M | -72.79M | -72.4M | -57.07M | -57.77M | -54.86M | -54.12M | -53.69M | -46.43M | -40.7M | -34.09M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -418.44M | -340.33M | -278.69M | -224.58M | -152.54M | -133.99M | -87.79M | -74.25M | -71.95M | -54.87M | -73.38M | -66.66M | -60.5M | -62.51M | -48.4M | -49.82M | -47.25M | -47.24M | -47.59M | -40.72M | -35.12M | -28.35M |
Add to Watchlist
Select watchlists to add or remove VKTX